University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Gabitass, R"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.

Article

Annels, NE, Shaw, VE, Gabitass, RF, Billingham, L, Corrie, P, Eatock, M, Valle, J, Smith, D, Wadsley, J, Cunningham, D, Pandha, H, Neoptolemos, JP and Middleton, G (2013) The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer. Cancer Immunol Immunother.

Gabitass, RF, Annels, NE, Stocken, DD, Pandha, HA and Middleton, GW (2011) Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother.

Gabitass, RF, Annels, NE, Crawshaw, J, Pandha, HS and Middleton, GW (2011) Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC). JOURNAL OF CLINICAL ONCOLOGY, 29 (15).

Gabitass, RF, Annels, NE, Pandha, HS and Middleton, AW (2010) Prevalence and prognostic significance of myeloid-derived suppressor cells and regulatory T cells in pancreatic and esophagogastric cancer JOURNAL OF CLINICAL ONCOLOGY, 28 (15).

This list was generated on Fri Nov 24 02:48:25 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800